- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5685 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone having an oxo group in position 17, e.g. androsterone
Patent holdings for IPC class A61K 31/5685
Total number of patents in this class: 274
10-year publication summary
|
23
|
29
|
22
|
34
|
30
|
24
|
24
|
25
|
19
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10178 |
10 |
| Endorecherche, Inc. | 21 |
10 |
| Duke University | 3181 |
9 |
| Allergan, Inc. | 2159 |
8 |
| The Johns Hopkins University | 5907 |
6 |
| Havah Therapeutics Pty Ltd | 20 |
6 |
| Celgene Quanticel Research, Inc. | 154 |
5 |
| Eli Lilly and Company | 4101 |
5 |
| Universidad Pablo de Olavide | 45 |
5 |
| Windtree Therapeutics, Inc. | 32 |
5 |
| Société des Produits Nestlé S.A. | 10044 |
4 |
| Board of Regents, The University of Texas System | 6135 |
4 |
| Antares Pharma, Inc. | 171 |
4 |
| Curadis GmbH | 4 |
4 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3267 |
4 |
| Lucolas-m.d. Ltd. | 5 |
4 |
| Pandora Endocrine Innovation B.V. | 5 |
4 |
| Seismic Pharmaceuticals Operations LLC | 8 |
4 |
| Pfizer Inc. | 3404 |
3 |
| Assistance Publique - Hopitaux de Paris | 1058 |
3 |
| Other owners | 167 |